RFP QuestBeta
ClosedStage · preprocurement

Department of Health and Social Care

Call for information/EOI for neutralising antibodies.

Medical Equipment & PharmaCPV 33600000
Value£1
Deadline31 Mar 2022
Published5 Oct 2021
RegionUK-wide
Timeline
Published 5 Oct 2021ClosedCloses 31 Mar 2022
Contract value in context
£1total contract value
median £123k
this tender£0£16.5m

This sits below the typical range for Medical Equipment & Pharmaceuticals contracts — a smaller, more accessible award. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

DHSC invites suppliers to submit an EOI on neutralising antibodies and binding site, clinical trials on efficacy, safety for preventing or treating COVID-19 infection, dose&frequency, formats/routes for administering to patients, monitoring adverse affects, efficacy against SARSCoV- 2 variants, supply availability for 2021- 2022 and future years and plans for regulatory approval in the UK, if not yet approved. **Updated information on 9th December 2021** The Therapeutics Taskforce is responsible for the end-to-end provision of treatments for COVID-19 in the UK, from the initial identification of potential therapeutics, to trialing treatments as part of an advanced programme of clinical trials, and their eventual deployment at scale to the patient population.

These safe and effective treatments are vital for lessening the severity and impact of COVID-19 in individuals and communities.

The Taskforce is seeking to gather information in respect of neutralising antibodies that can be deployed in a hospital or community setting.

Therapeutics suppliers must provide evidence of their therapies' potential efficacy and progress in trials, monitoring and safety.

The market engagement will take the form of a webinar held on Thursday 16th December 2021.

The webinar will take interested suppliers through the requirement outlined in this Prior Information Notice and will provide an opportunity for suppliers to ask questions.

To sign up to join the webinar please visit: https://www.eventbrite.co.uk/e/prior-information-notice-antiviral-drug-supply-for-covid-19-webinar-tickets-225298643307 We are inviting suppliers to register their interest in the PIN by downloading a questionnaire via the Atamis platform, and sending a completed version to http://health.atamis.co.uk by 13:00 on 23rd December 2021.

Responses to this questionnaire will be kept in confidence and will inform the Taskforce's market research.

Suppliers are not required to fill out a questionnaire before attending the webinar.

Any information shared in the webinar will be shared with all suppliers via the Atamis platform after the market engagement period associated with this PIN closes on Thursday 23rd December 2021.

Key requirements

What the supplier must deliver

01

2 variants, supply availability for 2021-

2 variants, supply availability for 2021-.

02

The Therapeutics Taskforce is responsible for

The Therapeutics Taskforce is responsible for the end-to-end provision of treatments for COVID-19 in the UK, from the initial identification of potential therapeutics, to trialing treatments as part of an advanced programme of clinical trials, and their eventual deployment at scale to the patient population.

03

Therapeutics suppliers must provide evidence of their

Therapeutics suppliers must provide evidence of their therapies' potential efficacy and progress in trials, monitoring and safety.

04

The webinar will take interested suppliers through

The webinar will take interested suppliers through the requirement outlined in this Prior Information Notice and will provide an opportunity for suppliers to ask questions.

05

Suppliers are not required to fill out

Suppliers are not required to fill out a questionnaire before attending the webinar.

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at Department of Health and Social Care, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
b16a9c81-97ef-4281-8a4f-5486929f4621
Stage
preprocurement · Closed
Source
Contracts Finder
Buyer ref
CF-0367000D0O000000rwimUAA2
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Medical Equipment & Pharmaceuticals

Assembling the market network…

Department of Health and Social Care’s tender network

Assembling the network…